125 related articles for article (PubMed ID: 1097512)
21. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
22. Cytophilic and cytotoxic antibodies in sera of rabbits after allogeneic skin grafts.
Matej H; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1975; 23(3):329-33. PubMed ID: 766723
[TBL] [Abstract][Full Text] [Related]
23. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of immunological enhancement of H-2-incompatible skin grafts in mice.
Chutná J
Transplantation; 1971 Jul; 12(1):28-35. PubMed ID: 4932695
[No Abstract] [Full Text] [Related]
25. Mechanisms of immunologic enhancement.
Amos DB; Cohen I; Klein WJ
Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
[No Abstract] [Full Text] [Related]
26. Studies on heterologous antilymphocyte and antithymocyte sera. V. Loss or retention of immunosuppressive activity after absorption with sheep erythrocytes.
Barth RF; Singla O
J Immunol; 1972 Nov; 109(5):1003-8. PubMed ID: 4562422
[No Abstract] [Full Text] [Related]
27. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
Wasfie T; Reed E; Suciu-Foca N; Hardy MA
Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
[TBL] [Abstract][Full Text] [Related]
28. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
[TBL] [Abstract][Full Text] [Related]
29. Protective action of homologous serum component on graft rejection.
Hasek M; Karakoz I; Skamene E; Chutna J; Nouza K; Bubenik J; Nemec M; Sovova V
Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266
[No Abstract] [Full Text] [Related]
30. Dynamics of immunologic enhancement.
Kaliss N
Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
[No Abstract] [Full Text] [Related]
31. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
32. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
Nouza K; Hilgert I; Nĕmec M; Kristofová H
Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
[No Abstract] [Full Text] [Related]
33. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
34. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
[TBL] [Abstract][Full Text] [Related]
35. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
36. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
37. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
[TBL] [Abstract][Full Text] [Related]
38. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
Klein J; Geib R; Chiang C; Hauptfeld V
J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
[TBL] [Abstract][Full Text] [Related]
39. Prolongation of skin allograft survival in ATS-treated mice by post-transplant injections of species antigenic extracts.
Chutná J; Sládecek M; Holán V; Hasek M
Folia Biol (Praha); 1984; 30(2):109-22. PubMed ID: 6233181
[TBL] [Abstract][Full Text] [Related]
40. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
Perry LL; Williams IR
J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
